Supervised Exercise Training Reduces Plasma Levels of the Endothelial Inflammatory Markers E-Selectin and ICAM-1 in Patients With Peripheral Arterial Disease

被引:35
|
作者
Saetre, T. [1 ]
Enoksen, E. [2 ]
Lyberg, T. [3 ]
Stranden, E. [1 ,4 ]
Jorgensen, J. J. [1 ,4 ]
Sundhagen, J. O. [1 ]
Hisdal, J. [1 ]
机构
[1] Oslo Univ Hosp, Oslo Vasc Ctr, N-0514 Oslo, Aker, Norway
[2] Norwegian Sch Sport Sci, Oslo, Norway
[3] Oslo Univ Hosp, Clin Res Ctr, N-0514 Oslo, Aker, Norway
[4] Univ Oslo, Oslo, Norway
关键词
peripheral arterial disease; exercise training; vascular inflammation; endothelial adhesion molecules; INTERCELLULAR-ADHESION MOLECULE-1; OSLO BALLOON ANGIOPLASTY; ISCHEMIC-HEART-DISEASE; APPARENTLY HEALTHY-MEN; INTERMITTENT CLAUDICATION; CONSERVATIVE TREATMENT; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; VCAM-1; OBACT;
D O I
10.1177/0003319710385338
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Elevated plasma levels of vascular inflammatory markers have been reported in patients with peripheral arterial disease (PAD). We assessed the effect of supervised exercise training (ET) on vascular inflammation, hypothesizing that ET reduces plasma levels of the endothelial adhesion molecules E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1). Twenty-nine patients with PAD underwent a supervised ET program for 8 weeks. Before and after ET, walking distances (pain-free, PWD; maximal, MWD) were determined by a standard treadmill test. Plasma levels of E-selectin and ICAM-1 were significantly reduced (E-selectin: 45.5-40.4 ng/mL, P = .013); ICAM-1: 342.0-298.0 ng/mL, P = .016). VCAM-1 levels were unchanged. Walking distances increased significantly (PWD: median 77-150 m, P < .001; MWD: median 306-535 m, P < .001). In conclusion, 8 weeks of ET in patients with PAD reduces plasma levels of the specific endothelium-derived inflammatory markers E-selectin and ICAM-1.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 30 条
  • [21] Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1
    Parissis, JT
    Korovesis, S
    Giazitzoglou, E
    Kalivas, P
    Katritsis, D
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 83 (01) : 13 - 21
  • [22] Plasma levels of β2-microglobulin, a biomarker of peripheral arterial disease, are not affected by maximal leg exercise in patients with intermittent claudication
    Busti, Chiara
    Migliacci, Rino
    Falcinelli, Emanuela
    Gresele, Paolo
    ATHEROSCLEROSIS, 2009, 203 (01) : 38 - 40
  • [23] Exercise Training Improves Brachial Artery Endothelial Function, but Does Not Alter Inflammatory Biomarkers in Patients with Peripheral Artery Disease: a Systematic Review and Meta-analysis
    Lee, Junghoon
    Zarezadehmehrizi, Aliasghar
    LaVoy, Emily C.
    Markofski, Melissa M.
    Park, Yoonjung
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (03) : 585 - 597
  • [24] Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages
    Mangiafico, RA
    Malatino, LS
    Santonocito, M
    Sarnataro, F
    Dell'arte, S
    Messina, R
    Santangelo, B
    PANMINERVA MEDICA, 1999, 41 (01) : 22 - 26
  • [25] The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X
    Siminiak, T
    Smielecki, J
    Rzezniczak, J
    Kazmierczak, M
    Kalawski, R
    Wysocki, H
    CORONARY ARTERY DISEASE, 1999, 10 (04) : 235 - 240
  • [26] ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism
    Chen, Li
    Zhao, Qian
    Wang, Xu-Liang
    You, Ran
    Zhang, Yi-Hua
    Ji, Hui
    Lai, Yi-Sheng
    VASCULAR PHARMACOLOGY, 2011, 55 (5-6) : 135 - 142
  • [27] Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease
    Wieczor, Radoslaw
    Gadomska, Grazyna
    Ruszkowska-Ciastek, Barbara
    Stankowska, Katarzyna
    Budzynski, Jacek
    Fabisiak, Jacek
    Suppan, Karol
    Pulkowski, Grzegorz
    Rosc, Danuta
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2015, 16 (11): : 948 - 956
  • [28] Sex-based difference in functional performance and quality of life 1 year after supervised exercise training in patients with symptomatic peripheral artery disease
    Lanzi, Stefano
    Pousaz, Anina
    Calanca, Luca
    Mazzolai, Lucia
    VASCULAR MEDICINE, 2025,
  • [29] Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease
    Findley, Clarence M.
    Mitchell, Robert G.
    Duscha, Brian D.
    Annex, Brian H.
    Kontos, Christopher D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) : 387 - 393
  • [30] Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease2 型糖尿病对外周动脉疾病患者血浆内的血管内皮生长因子及其可溶性受体浓度的影响
    Radosław Wieczór
    Grażyna Gadomska
    Barbara Ruszkowska-Ciastek
    Katarzyna Stankowska
    Jacek Budzyński
    Jacek Fabisiak
    Karol Suppan
    Grzegorz Pulkowski
    Danuta Rość
    Journal of Zhejiang University-SCIENCE B, 2015, 16 : 948 - 956